GEn1E Lifesciences
GEn1E Lifesciences is a clinical-stage biotechnology company utilizing an AI platform to develop immunomodulatory therapies for inflammatory and rare diseases.
Contact for pricingWeb
Visit websitegen1e.com
Compare with AidocExplore GEn1E Lifesciences alternativesOverview
GEn1E Lifesciences is a clinical-stage biotechnology company utilizing an AI platform to develop immunomodulatory therapies for inflammatory and rare diseases. Key features include the identification of allosteric binding pockets on kinases such as p38, MK2, and ERK, enabling specific targeting without the immunosuppressive effects of traditional ATP-binding inhibitors. The company maintains a pipeline of over 21 selective immunomodulators, with the lead candidate GEn-1124 currently in a Phase 2 study for ARDS. This technology is used by pharmaceutical researchers to address conditions with no effective treatments. Pricing is not publicly available.
Key features
- Identification of allosteric binding pockets for kinase targets
- Development of 21+ novel selective immunomodulators
- Phase 2 clinical trials for GEn-1124 in ARDS treatment
- Specific targeting of p38, MK2, and ERK kinases without immunosuppression
Pricing
Use cases
- Treating Acute Respiratory Distress Syndrome (ARDS)
- Developing therapies for rare and inflammatory diseases
- Targeting kinase dysregulation without off-target toxicity
Who it is for
Biotech researchersclinical developers
Integrations
SilcsBioInflect HealthVituity
How we verified this
Company, pricing, and feature details come from the primary sources below and our latest verification pass. When sources disagree, the official source and the most recent check win.
Last verified 09/02/2026Verified sources: 3
Alternatives
Tools you can use instead
Aidoc
Aidoc provides a unified healthcare AI platform designed to tackle fragmented healthcare systems by improving workflows, data accuracy, and patient care.
API
Science & Engineering
DataRobot
DataRobot provides an enterprise agent workforce platform designed to unify complex environments and manage the full agent lifecycle.
API
Science & Engineering
